The impact of atherothrombotic events on resource use and cost in patients with peripheral arterial disease

被引:0
|
作者
Caro, J
Migliaccio-Walle, K
Ishak, K
O'Brien, JA
机构
[1] Caro Res Inst, Concord, MA USA
[2] Caro Res Inst, Dorval, PQ, Canada
关键词
D O I
10.1016/S1098-3015(10)64141-1
中图分类号
F [经济];
学科分类号
02 ;
摘要
引用
收藏
页码:316 / 316
页数:1
相关论文
共 50 条
  • [41] Impact of peripheral arterial disease in patients with diabetes: Results from PROactive
    Dormandy, John A.
    Betteridge, John
    Schernthaner, Guntram
    Pirags, Valdis
    Norgren, Lars
    DIABETES, 2008, 57 : A86 - A86
  • [42] Clinical impact of the infrapatellar location in symptomatic peripheral arterial disease patients
    Chiabrando, Juan G.
    Garagoli, Fernando D.
    Abraham-Foscolo, Maria M.
    Corna, Giuliana
    de-los-Milagros-Fleitas, Maria
    Valle-Raleigh, Juan
    Medina-de-Chazal, Horacio A.
    Berrocal, Daniel H.
    Rabellino, Jose M.
    Bluro, Ignacio M.
    ARCHIVOS DE CARDIOLOGIA DE MEXICO, 2023, 93 (03): : 318 - 327
  • [43] Roxifiban in the prevention of ischemic events in peripheral arterial disease
    Hiatt, WR
    Dormandy, JA
    Norgran, L
    Hirsch, A
    Creager, M
    Califf, R
    Murray, G
    CIRCULATION, 2002, 106 (19) : 474 - 474
  • [44] Ticagrelor for Secondary Prevention of Atherothrombotic Events in Patients With Multivessel Coronary Disease
    Bansilal, Sameer
    Bonaca, Marc P.
    Cornel, Jan H.
    Storey, Robert F.
    Bhatt, Deepak L.
    Steg, Gabriel
    Im, Kyungah
    Murphy, Sabina A.
    Angiolillo, Dominick J.
    Kiss, Robert G.
    Parkhomenko, Alexander N.
    Lopez-Sendon, Jose
    Isaza, Daniel
    Goudev, Assen
    Kontny, Frederic
    Held, Peter
    Jensen, Eva C.
    Braunwald, Eugene
    Sabatine, Marc S.
    Ophuis, A. J. Oude
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2018, 71 (05) : 489 - 496
  • [45] Angio-Seal Use in Patients With Peripheral Arterial Disease (ASPIRE)
    Katzenschlager, Reinhold
    Tischler, Reinhold
    Kalchhauser, Georg
    Panny, Michael
    Hirschl, Mirko
    ANGIOLOGY, 2009, 60 (05) : 536 - 538
  • [46] Use of Cardioprotective Medications Remain Underused in Patients with Peripheral Arterial Disease
    Subherwal, Sumeet
    Patel, Manesh R.
    Kober, Lars
    Jones, William S.
    Gislason, Gunnar H.
    Berger, Jeffrey S.
    Torp-Pedersen, Christian
    Fosbol, Emil L.
    CIRCULATION, 2011, 124 (21)
  • [47] Statin use and functional decline in patients with and without peripheral arterial disease
    Giri, J
    McDermott, MM
    Greenland, P
    Guralnik, JM
    Criqui, MH
    Liu, K
    Ferrucci, L
    Green, D
    Schneider, JR
    Tian, L
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2006, 47 (05) : 998 - 1004
  • [48] Characteristics and Adverse Events in Acute Coronary Syndrome Patients with a History of Peripheral Arterial Disease
    Castro, Iran
    Fontana Filho, Hugo
    ARQUIVOS BRASILEIROS DE CARDIOLOGIA, 2019, 113 (03) : 373 - 373
  • [49] Risk Factor Control and Major Adverse Cardiovascular Events in Patients With Peripheral Arterial Disease
    Parvar, Saman L.
    Nicholls, Stephen J.
    Lincoff, A. M.
    Menon, Venu
    Riesmeyer, Jeffrey S.
    Ruotolo, Giacomo
    Wolski, Kathy
    McErlean, Ellen
    Nissen, Steven E.
    CIRCULATION, 2017, 136
  • [50] Peripheral arterial obliterative disease - Cost of illness in France
    Montron, A
    Guignard, E
    Pelc, A
    Comte, S
    PHARMACOECONOMICS, 1998, 13 (01) : 51 - 59